While skin conditions are often visible, their burden can extend far beyond the skin. At any given time, almost one in three people struggle with recurrent skin problems, affecting individuals of all ...
Children with IgA vasculitis who present with severe persistent skin manifestations, such as hemorrhagic vesicles, ulceration, or necrosis, are at higher risk for relapse and should be followed for a ...
The drug inhibits progression of epidermolysis bullosa in skin. Recessive dystrophic pidermolysis bullosa (RDEB) leads to excessive deposition of fibrosis (COL I) in the skin in response to skin ...
CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results